ID   EHBC-512
AC   CVCL_WI70
DR   CCRID; 4201PAT-CCTCC00279
DR   Wikidata; Q93539204
RX   DOI=10.3724/SP.J.1008.2009.01115;
RX   Patent=CN101824397B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200911.
CC   Population: Chinese.
CC   Doubling time: 48 hours (DOI=10.3724/SP.J.1008.2009.01115).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
RX   DOI=10.3724/SP.J.1008.2009.01115;
RA   Zou Q.-F., Hou Y., Liu J., Ge R.-L., Shen F.;
RT   "Establishment and characterization of a human hepatocellular
RT   carcinoma cell line EHBC-512.";
RL   Di 2 Jun Yi Da Xue Xue Bao 30:1115-1118(2009).
//
RX   Patent=CN101824397B;
RA   Hou Y., Liu J., Shen F., Ge R.-L., Zou Q.-F.;
RT   "Hepatoma cell line EHBC-512 and application thereof.";
RL   Patent number CN101824397B, 06-Jun-2012.
//